Skip to main content
Top
Published in: Journal of Gastroenterology 1/2011

01-01-2011 | Original Article—Liver, Pancreas, and Biliary Tract

Increased liver elasticity in patients with biliary obstruction

Authors: Yoko Yashima, Takeshi Tsujino, Ryota Masuzaki, Yousuke Nakai, Kenji Hirano, Ryosuke Tateishi, Naoki Sasahira, Hiroyuki Isayama, Minoru Tada, Haruhiko Yoshida, Takao Kawabe, Masao Omata

Published in: Journal of Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Transient elastography (with the FibroScan® apparatus) is a recently developed method for evaluating the severity of liver fibrosis by measuring liver elasticity. Liver elasticity may differ from the normal level in patients with obstructive jaundice because the retained bile may expand the liver. Because little is known about liver elasticity in patients with obstructive jaundice, we evaluated this feature in these patients.

Methods

Between April 2007 and April 2008, 178 patients with biliary or pancreatic disease underwent transient elastography at the University of Tokyo Hospital. We excluded 77 patients because of concomitant cirrhotic liver disease, liver tumors, or a history of abdominal surgery. The remaining 101 patients were included in the study and were divided into obstructive jaundice (OJ; n = 43) and nonobstructive jaundice (NJ; n = 58) groups.

Results

The basic patient characteristics did not differ significantly between the two groups, except for the causative diseases. The mean liver elasticity was significantly higher in the OJ group than in the NJ group (12.0 vs. 6.2 kPa, p < 0.01). In 24 patients from the OJ group, transient elastography was performed before and after biliary drainage; there was a marked reduction in the elasticity after the procedure in these patients (p < 0.01).

Conclusions

Liver elasticity increases in patients with biliary obstruction. This increase is reduced after biliary drainage, implying that the increased FibroScan® values before drainage are not due to liver fibrosis, but to temporarily increased elasticity.
Literature
2.
go back to reference Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477–81.CrossRefPubMed Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477–81.CrossRefPubMed
3.
go back to reference Sheela H, Seela S, Caldwell C, Boyer JL, Jain D. Liver biopsy: evolving role in the new millennium. J Clin Gastroenterol. 2005;39:603–10.CrossRefPubMed Sheela H, Seela S, Caldwell C, Boyer JL, Jain D. Liver biopsy: evolving role in the new millennium. J Clin Gastroenterol. 2005;39:603–10.CrossRefPubMed
4.
go back to reference Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24:289–93.CrossRefPubMed Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24:289–93.CrossRefPubMed
5.
go back to reference Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1:523–5.CrossRefPubMed Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1:523–5.CrossRefPubMed
6.
go back to reference Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology. 1991;178:253–8.PubMed Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology. 1991;178:253–8.PubMed
7.
go back to reference Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28:705–12.CrossRefPubMed Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28:705–12.CrossRefPubMed
8.
go back to reference Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36:437–41.CrossRefPubMed Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36:437–41.CrossRefPubMed
9.
go back to reference van der Poorten D, Kwok A, Lam T, Ridley L, Jones DB, Ngu MC, et al. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J. 2006;36:692–9.CrossRefPubMed van der Poorten D, Kwok A, Lam T, Ridley L, Jones DB, Ngu MC, et al. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J. 2006;36:692–9.CrossRefPubMed
10.
go back to reference Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut. 2005;54:419–25.CrossRefPubMed Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut. 2005;54:419–25.CrossRefPubMed
11.
go back to reference Ahmed A, Samuels SL, Keeffe EB, Cheung RC. Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol. 2001;96:233–7.CrossRefPubMed Ahmed A, Samuels SL, Keeffe EB, Cheung RC. Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol. 2001;96:233–7.CrossRefPubMed
12.
go back to reference Kowdley KV, Aggarwal AM, Sachs PB. Delayed hemorrhage after percutaneous liver biopsy. Role of therapeutic angiography. J Clin Gastroenterol. 1994;19:50–3.CrossRefPubMed Kowdley KV, Aggarwal AM, Sachs PB. Delayed hemorrhage after percutaneous liver biopsy. Role of therapeutic angiography. J Clin Gastroenterol. 1994;19:50–3.CrossRefPubMed
13.
go back to reference Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.CrossRefPubMed Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.CrossRefPubMed
14.
go back to reference Cespedes I, Ophir J, Ponnekanti H, Maklad N. Elastography: Elasticity imaging using ultrasound with application to muscle and breast in vivo. Ultrason Imaging. 1993;15:73–88.CrossRefPubMed Cespedes I, Ophir J, Ponnekanti H, Maklad N. Elastography: Elasticity imaging using ultrasound with application to muscle and breast in vivo. Ultrason Imaging. 1993;15:73–88.CrossRefPubMed
15.
go back to reference Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity in biological tissues. Ultrason Imaging. 1991;13:111–34.CrossRefPubMed Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity in biological tissues. Ultrason Imaging. 1991;13:111–34.CrossRefPubMed
16.
go back to reference Parker KJ, Fu D, Graceswki SM, Yeung F, Levinson SF. Vibration sonoelastography and the detectability of lesions. Ultrasound Med Biol. 1998;24:1437–47.CrossRefPubMed Parker KJ, Fu D, Graceswki SM, Yeung F, Levinson SF. Vibration sonoelastography and the detectability of lesions. Ultrasound Med Biol. 1998;24:1437–47.CrossRefPubMed
17.
go back to reference Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol. 2002;28:467–74.CrossRefPubMed Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol. 2002;28:467–74.CrossRefPubMed
18.
go back to reference Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M. Shear elasticity probe for soft tissues with 1D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49:436–46.CrossRefPubMed Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M. Shear elasticity probe for soft tissues with 1D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49:436–46.CrossRefPubMed
19.
go back to reference Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47.CrossRefPubMed Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47.CrossRefPubMed
20.
go back to reference Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Hasser M, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–50.CrossRefPubMed Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Hasser M, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–50.CrossRefPubMed
21.
go back to reference Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bsil B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–8.CrossRefPubMed Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bsil B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–8.CrossRefPubMed
22.
go back to reference Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–73.CrossRefPubMed Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–73.CrossRefPubMed
23.
go back to reference Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, Zeuzem S, et al. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol. 2007;188:758–64.CrossRefPubMed Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, Zeuzem S, et al. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol. 2007;188:758–64.CrossRefPubMed
24.
go back to reference Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960–74.CrossRefPubMed Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960–74.CrossRefPubMed
25.
go back to reference Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–7.CrossRefPubMed Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–7.CrossRefPubMed
26.
go back to reference Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.CrossRefPubMed Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.CrossRefPubMed
27.
go back to reference Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–24.CrossRefPubMed Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–24.CrossRefPubMed
28.
go back to reference Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–13.CrossRefPubMed Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–13.CrossRefPubMed
29.
go back to reference Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–5.CrossRefPubMed Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–5.CrossRefPubMed
30.
go back to reference Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–4.CrossRefPubMed Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–4.CrossRefPubMed
31.
go back to reference Hammel P, Couvelard A, O’Toole D, Ratouis A, Sauvanat A, Flejou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med. 2001;344:418–23.CrossRefPubMed Hammel P, Couvelard A, O’Toole D, Ratouis A, Sauvanat A, Flejou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med. 2001;344:418–23.CrossRefPubMed
32.
go back to reference Iida A, Yoshidome H, Shida T, Takano S, Takeuchi D, Kimura F, et al. Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia? Shock. 2009;31:397–403.CrossRefPubMed Iida A, Yoshidome H, Shida T, Takano S, Takeuchi D, Kimura F, et al. Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia? Shock. 2009;31:397–403.CrossRefPubMed
Metadata
Title
Increased liver elasticity in patients with biliary obstruction
Authors
Yoko Yashima
Takeshi Tsujino
Ryota Masuzaki
Yousuke Nakai
Kenji Hirano
Ryosuke Tateishi
Naoki Sasahira
Hiroyuki Isayama
Minoru Tada
Haruhiko Yoshida
Takao Kawabe
Masao Omata
Publication date
01-01-2011
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 1/2011
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0290-9

Other articles of this Issue 1/2011

Journal of Gastroenterology 1/2011 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Serum IgG4-negative autoimmune pancreatitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine